Certain populations are more susceptible to DILE. Genetic factors, such as N-acetyltransferase 2 (NAT2) acetylator status, can influence a person's risk. Slow acetylators are more likely to develop DILE when exposed to drugs like hydralazine and procainamide. Additionally, older age, female gender, and prolonged drug exposure increase the likelihood of developing this condition.
